You are here

diabetes

Dexcom’s Jack Leach discusses preparations for G7 launch next year

Medtech Dive

Thu, 12/15/22 - 10:48 am

continuous glucose monitoring

Lilly and Pfizer fight for new territory in obesity and diabetes

EP Vantage

Thu, 12/15/22 - 10:46 am

‘Diabesity’ marketing set to swell as Novo preps relaunch of weight-loss drug

Medical Marketing and Media

Wed, 12/14/22 - 10:36 am

pharma marketing

Tandem Set for M&A in One of Diabetes Tech Most Eventful Years

Medical Devices and Diagnostics Industry

Tue, 12/13/22 - 11:49 pm

Tandem Diabetes Care

Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal

Medtech Dive

Tue, 12/13/22 - 10:38 am

Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025

Fierce Pharma

Tue, 12/6/22 - 09:00 pm

type 2 diabetes

drug manufacturing

Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report

Endpoints

Mon, 11/21/22 - 06:34 pm

type 2 diabetes

drug manufacturing

Medtronic begins U.S. launch of 7-day insulin infusion set

Fierce Biotech

Thu, 11/17/22 - 11:40 pm

insulin infusion device

Lilly wins FDA approval for second interchangeable insulin biosimilar

Endpoints

Thu, 11/17/22 - 11:27 pm

Lilly’s new diabetes management platform to integrate Dexcom CGM

Medtech Dive

Wed, 11/9/22 - 10:44 am

Lilly sales of new diabetes drug accelerate on rising patient demand

BioPharma Dive

Tue, 11/1/22 - 07:10 pm

Just announced: upcoming late-stage clinical trials in weight loss and diabetes

Clinical Trials Arena

Sun, 10/23/22 - 07:09 pm

clinical trials

Eyenuk raises $26M for diabetic retinopathy screening tech

MedCity News

Tue, 10/18/22 - 10:49 am

diabetic retinopathy

The global diabetes crisis few are talking about

Stat

Thu, 10/13/22 - 09:42 am

type 1 diabetes

Eli Lilly tasks Nimbus with hitting a 'high-value' target for diabetes, obesity

Endpoints

Tue, 10/11/22 - 10:33 am

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug

Fierce Pharma

Mon, 10/10/22 - 10:57 am

Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win

Fierce Biotech

Wed, 10/5/22 - 07:11 pm

Merck celebrates another win in Januvia patent battle against Viatris

Endpoints

Sun, 10/2/22 - 07:46 pm

EASD 2022 – Pfizer’s oral GLP-1s struggle for a therapeutic window

EP Vantage

Fri, 09/23/22 - 10:34 am

Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space

BioSpace

Thu, 09/22/22 - 10:14 am

clinical trials

type 2 diabetes

Pages